UCB, a Belgium-based global biopharmaceutical company, announced on Wednesday that it has introduced its Make HStory, an educational campaign that offers tools and resources for those living with hidradenitis suppurativa (HS) and their dermatologists.

HS is a chronic, complex, and debilitating inflammatory skin disease that impacts approximately 1% of the population in most studied countries, and large unmet needs remain. Make HStory intends to help increase understanding of the disease and to empower patients to have conversations with their dermatologist about management options.

The new campaign has been developed in collaboration with individuals living with HS and their dermatologists. It features stories of those living with HS, informational videos, and interactive tools and resources for those seeking management options, daily care, and information about HS. It was developed as a partner to the previously launched Make HStory medical education campaign, and offers educational information, downloadable resources, a strong online and streaming service video presence, and social media, including Instagram and Facebook.